Precision Neuroscience
Develops a brain-computer interface intended to help people with paralysis operate digital devices.
$250MSeries D
ParticipantKI
Korea Investment Partners
Activity from announced rounds
Activity in this selectionOct 21, 2026 · Sep 22, 2026
Korea Investment Partners is the investment manager named in Q-Factor and BreezeBio financing histories.
Recorded funding activity
Q-Factor develops neutral-atom quantum computing. BreezeBio develops genetic medicines using non-viral nanoparticle delivery. The stored Precision Neuroscience relationship remains in draft rather than being published with the investor profile.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $250M 1 disclosed · full round size, not this investor’s share